Navigation Links
Dilon Diagnostics Gamma-Guided Localization System Cleared by FDA
Date:12/14/2009

GammaLMc® Helps Locate Breast Lesions Quickly and Accurately for Biopsy

Newport News, VA (Vocus) December 14, 2009 -- Dilon Diagnostics announced today that the U.S. Food and Drug Administration (FDA) has granted 510(k) clearance for its lesion-localization system for molecular imaging biopsy guidance.

GammaLMc® is a complementary technology to Dilon’s cornerstone product, the Dilon 6800 Gamma Camera. The GammaLMc® (GL) system will help doctors accurately locate breast lesions and enable gamma-guided biopsies, particularly useful for patients that have findings on the Dilon system that are not revealed with other imaging modalities.

The GammaLMc® system utilizes a CorreLocator™ paddle and a StereoView™ imaging collimator system - a technique similar to that used in stereotactic X-ray localization, and the GammaLMc® software calculates the specific location of the suspect lesion. The compact design allows for breast biopsies with optimal patient comfort; and the entire system is small and portable, allowing physicians to perform molecular imaging guided biopsy procedures anywhere on site.

“Thanks to the superior performance of the Dilon 6800 camera combined with this new biopsy-guidance capability, physicians will find it easier to locate suspicious lesions seen with molecular breast imaging, greatly facilitating and expediting the biopsy process,” said Robert Moussa, President and CEO of Dilon Diagnostics. “This recent innovation helps physicians improve patient management and confidently deliver faster, more accurate results to their anxious patients.”

About Dilon Diagnostics:
Dilon Diagnostics, a brand of Dilon Technologies Inc. is bringing innovative new medical imaging products to market. Dilon’s cornerstone product, the Dilon 6800, is a high-resolution, small field-of-view gamma camera, optimized to perform BSGI, a molecular breast imaging procedure which images the metabolic activity of breast lesions through radiotracer uptake. Many leading medical centers around the country are now offering BSGI to their patients, including: Cornell University Medical Center, New York; George Washington University Medical Center, Washington, D.C.; and The Rose, Houston. For more information on Dilon Technologies please visit www.dilon.com.

###

Read the full story at http://www.prweb.com/releases/2009/12/prweb3341114.htm.


'/>"/>
Source: PRWeb
Copyright©2009 Vocus, Inc.
All rights reserved

Related medicine news :

1. Dilon Technologies Explores Improvements in Molecular Breast Imaging
2. Dilon Technologies Appoints New VP of Sales & Business Development
3. Settlement Reached Between Dilon Technologies and Naviscan on Patent Rights
4. Dilon Technologies Announces National Agreement with MedAssets
5. Dilon Technologies Signs Amerinet for Breast-Specific Gamma Imaging
6. Dilon Technologies Slant15(TM) and LEHR Collimators Enhance Imaging Capabilities
7. Dilon Technologies Leads Molecular Breast Imaging Expansion
8. Quest Diagnostics to Speak at the Bear Stearns Healthcare Conference
9. Pathway Diagnostics Announces Commercial Availability of SensiTrop(TM) HIV Co-receptor Tropism Assay
10. Hypertension Diagnostics Announces Fiscal Year 2007 Results
11. Foundation Venture Capital Group, LLC Invests in Start Up Committed to Breast Cancer Diagnostics
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/22/2017)... Dallas, TX (PRWEB) , ... ... ... HCC Risk Adjustment solution leverages advanced data analytics to accurately understand each ... ensure proper reimbursement for a given population. This new solution helps transform ...
(Date:2/22/2017)... ... February 22, 2017 , ... Sideline Products participated in the ... national TV host Tom Seay and his production crew. Tom Seay’s program “Best ... around the world. Saddle Sidekicks will be featured on April 6, 2017. After ...
(Date:2/22/2017)... ... February 22, 2017 , ... ANGLESTRONG , the new ... now available on the App Store and Google Play . Florida-based ... the addiction and recovery industry, partnered with Angle to build ANGLESTRONG. The new recovery ...
(Date:2/22/2017)... , ... February 22, 2017 , ... A product of ... seem to derive a heart-protective benefit from eating soy foods, while others do not, ... men who are able to produce equol—a substance made by some types of “good” ...
(Date:2/22/2017)... GA (PRWEB) , ... February 22, 2017 , ... Super-Sod ... 25 and 26 event in Athens, Georgia. , A shift from Super-Sod’s simple Athens ... in Georgia. , For the booth, grass seed plant manager Chris Roquemore constructed furniture ...
Breaking Medicine News(10 mins):
(Date:2/23/2017)... , Feb. 23, 2017  CTI BioPharma Corp. (CTI ... plans to report its fourth quarter and full year ... close of the U.S. financial markets. Following the announcement, ... conference call to discuss the results and provide a ... to the event can be obtained as follows: ...
(Date:2/22/2017)... NORTHVALE, N.J. , Feb. 22, 2017  Andre, ... a technology-based developer and manufacturer of innovative technologies and ... financial results reported on February 21, 2017 in the ... www.sec.gov . ADMT CEO Andre, DiMino stated ... with our business plan by devoting a larger portion ...
(Date:2/22/2017)... -- Ultra Clean Holdings, Inc. (Nasdaq: UCTT), a leading ... for the semiconductor capital equipment, flat panel, medical, ... results for the fourth quarter and fiscal year ... a year of extraordinary growth for UCT. Total ... together with continued focus on operational excellence resulted ...
Breaking Medicine Technology: